Lumora融资110万美元用于其技术的商业化
- 互联网2013年3月20日 17:25 点击:1449
MDx Firm Lumora Raises $1.1M to Support Technology Commercialization
Molecular diagnostics firm Lumora today said it raised £700,000 ($1.1 million) in a follow-on financing as the company plans on further commercializing its technology in the US and Europe.
Current investors Tate & Lyle Ventures, Catapult Ventures Managers, and Cambridge University participated in the financing, which the Cambridge, UK-based firm said will go toward efforts to further commercialize its diagnostic technologies and applications, including the BART (Bioluminescent Assay in Real Time) system. BART is a reporter system for use with isothermal nucleic acid amplification technologies.
"During this quarter we have made significant progress with a number of commercial deals and the funding will allow us to further develop new products, take advantage of new opportunities, and accelerate existing commercial agreements," Laurence Tisi, CEO of Lumora, said in a statement.
In the spring of 2011, Lumora raised $2.1 million in second-stage funding.
联系邮箱:kefu@labbase.net
版权与免责声明
- 凡本网注明“来源:来宝网”的所有作品,版权均属于来宝网,转载请必须注明来宝网, http://www.labbase.net,违反者本网将追究相关法律责任。
- 本网转载并注明自其它来源的作品,目的在于传递更多信息,并不代表本网赞同其观点或证实其内容的真实性,不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时,必须保留本网注明的作品来源,并自负版权等法律责任。
- 如涉及作品内容、版权等问题,请在作品发表之日起一周内与本网联系,否则视为放弃相关权利。